MICHELLE FINNEGAN: Open Payments
NPI 1073043691 · DOVER, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 12 payments from 5 companies in 2025. Trend: 2023 $602 · 2024 $733 · 2025 $319
Food & beverage: $319
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 3 | $111 |
| Sumitomo Pharma America, Inc. | 4 | $93 |
| COLOPLAST CORP | 3 | $75 |
| Sage Therapeutics, LLC | 1 | $25 |
| MILLICENT US INC | 1 | $15 |
Products named: GEMTESA, INTERSTIM, Altis, ALTAVIVA, ZURZUVAE, SpeediCath, INTRAROSA.
Industry payments across DE — which companies pay providers there.
